Organogenesis Holdings Inc. Updates Date and Time of Presentation at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
Organogenesis Holdings Inc. (Nasdaq: ORGO) announced a change in its presentation schedule for the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Organogenesis Holdings Inc. (Nasdaq: ORGO) announced a change in its presentation schedule for the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit. The company will now present on September 21, 2020, at 2:30 p.m. Eastern Time, instead of the previously scheduled time of September 22, 2020, at 4:10 p.m. Eastern Time. A live audio webcast of the presentation will be available on the company’s website, with a replay accessible for approximately 30 days post-event. Organogenesis specializes in regenerative medicine, providing solutions for advanced wound care and surgical needs.
Details
News Market Reaction – ORGO
The recorded move for ORGO in the trading session of this news was -0.98%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
CANTON, Mass., Sept. 17, 2020 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, today announced that the date and time of its presentation at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit has been updated.
Company management is now scheduled to conduct a presentation at the conference on Monday, September 21 at 2:30 p.m. Eastern Time. The company was previously scheduled to present on Tuesday, September 22 at 4:10 p.m. Eastern Time.
A live audio webcast of the conference presentation will be accessible by visiting the “Upcoming Events” section on the “Investor Relations” page of Organogenesis’s website www.organogenesis.com. An archive of the webcast will be available for replay following the conference for approximately 30 days.
About Organogenesis Holdings Inc.
Organogenesis Holdings Inc. is a leading regenerative medicine company offering a portfolio of bioactive and acellular biomaterials products in advanced wound care and surgical biologics, including orthopedics and spine. Organogenesis’s comprehensive portfolio is designed to treat a variety of patients with repair and regenerative needs. For more information, visit www.organogenesis.com.
Investor Inquiries: Westwicke Partners Mike Piccinino, CFA 443-213-0500 Press and Media Inquiries: Organogenesis Marcus Girolamo 817-688-4767
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.